Abstract
Norovirus (NoV) infection is the most common cause of acute gastroenteritis in humans of all ages worldwide. When cats are experimentally infected with feline norovirus (FNoV), they develop symptoms of acute gastroenteritis. Therefore, FNoV infection may serve as an animal model for the disease caused by human norovirus infection. In this study, we examined whether FNoV of cats infected with genogroup GVI are protected from reinfection with the same strain. The blood anti-FNoV IgG level was inversely correlated with the viral load in stool samples and the clinical score of FNoV-infected cats, but complete prevention of reinfection was not observed. These findings were similar to the results of a reinfection experiment with NoV in human volunteers.
Similar content being viewed by others
References
Bailey D, Thackray LB, Goodfellow IG (2008) A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J Virol 82(15):7725–7728
Bodnar L, Lorusso E, Di Martino B, Catella C, Lanave G, Elia G, Banyai K, Buonavoglia C, Martella V (2017) Identification of a novel canine norovirus. Infect Genet Evol 52:75–81
Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, Green KY (2009) Evolutionary dynamics of GII. 4 noroviruses over a 34-year period. J Virol 83(22):11890–11901
Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, Purcell RH, Purcell RH (2011) Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA 108(1):325–330
de Graaf M, van Beek J, Koopmans MP (2016) Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol 14(7):421–433
de Graaf M, Villabruna N, Koopmans MP (2017) Capturing norovirus transmission. Curr Opin Virol 22:64–70
Di Martino B, Di Profio F, Melegari I, Sarchese V, Cafiero MA, Robetto S, Aste G, Lanave G, Marsillo F, Martella V (2016) A novel feline norovirus in diarrheic cats. Infect Genet Evol 38:132–137
Di Martino B, Di Profio F, Melegari I, Sarchese V, Massirio I, Palermo G, Romito G, Lorusso E, Lanave G, Bodnar L, Buonavoglia C, Marsillo F, Green KY, Martella V (2017) Seroprevalence for norovirus genogroup II, IV and VI in dogs. Vet Microbiol 203:68–72
Foley J, Hurley K, Pesavento PA, Poland A, Pedersen NC (2006) Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants. J Feline Med Surg 8(1):55–61
Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361(18):1776–1785
Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB (1990) Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 161(1):18–21
Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW (2014) Advances in norovirus biology. Cell Host Microbe 15(6):668–680
Kniel KE (2014) The makings of a good human norovirus surrogate. Curr Opin Virol 4:85–90
Koopmans M, Duizer E (2004) Foodborne viruses: an emerging problem. Int J Food Microb 90(1):23–41
Liu G, Kahan SM, Jia Y, Karst SM (2009) Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. J Virol 83(13):6963–6968
Malm M, Uusi-Kerttula H, Vesikari T, Blazevic V (2014) High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children. J Infect Dis 210(11):1755–1762
Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinjé J, Parashar UD (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14(8):1224
Pinto P, Wang Q, Chen N, Dubovi EJ, Daniels JB, Millward LM, Buonavoglia C, Martella V, Saif LJ (2012) Discovery and genomic characterization of noroviruses from a gastroenteritis outbreak in domestic cats in the US. PLoS One 7(2):e32739
Phillips G, Lopman B, Tam CC, Iturriza-Gomara M, Brown D, Gray J (2009) Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis 9(1):63
Rocha-Pereira J, Kolawole AO, Verbeken E, Wobus CE, Neyts J (2016) Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model. Antivir Res 132:76–84
Rocha-Pereira J, Neyts J, Jochmans D (2014) Norovirus: targets and tools in antiviral drug discovery. Biochem Pharmacol 91(1):1–11
Rong S, Slade D, Floyd-Hawkins K, Wheeler D (2006) Characterization of a highly virulent feline calicivirus and attenuation of this virus. Virus Res 122(1):95–108
Singh BK, Glatt S, Ferrer JL, Koromyslova AD, Leuthold MM, Dunder J, Hansman GS (2015) Structural analysis of a feline norovirus protruding domain. Virology 474:181–185
Takanashi S, Hashira S, Matsunaga T, Yoshida A, Shiota T, Tung PG, Khamrin P, Okitsu S, Mizuguchi M, Igarashi T, Ushijima H (2009) Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol 44(2):161–163
Takano T, Kusuhara H, Kuroishi A, Takashina M, Doki T, Nishinaka T, Hohdatsu T (2015) Molecular characterization and pathogenicity of a genogroup GVI feline norovirus. Vet Microbiol 178(3):201–207
Takano T, Takadate Y, Doki T, Hohdatsu T (2016) Genetic characterization of feline bocavirus detected in cats in Japan. Arch Virol 161(10):2825–2828
Zhou YH, Purcell RH, Emerson SU (2004) An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22(20):2578–2585
Funding
This study was in part funded by JSPS KAKENHI Grant number JP16K08027, and Kitasato University Research Grant for Young Researchers (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All applicable national and institutional guidelines for the care and use of animals were followed. The animal experimentation protocol was approved by the President of Kitasato University through the judgment of the Institutional Animal Care and Use Committee of Kitasato University (Approval nos. 16-087 and 17-032). Specific-pathogen-free (SPF) cats were maintained in a temperature-controlled isolation facility. Sample sizes were determined based on our experience with FNoV infection models, and the minimum number of cats was used.
Additional information
Handling Editor: Sheela Ramamoorthy.
Rights and permissions
About this article
Cite this article
Takano, T., Hiramatsu, K., Matsuyama, M. et al. Viral shedding and clinical status of feline-norovirus-infected cats after reinfection with the same strain. Arch Virol 163, 1503–1510 (2018). https://doi.org/10.1007/s00705-018-3770-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-018-3770-5